In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 6, 2001, Pages 1688-1692

  Bonnefoy, Alain ^a   Guitton, Michele ^a   Delachaume, Carole ^a   Le Priol, Pascal ^a   Girard, Anne Marie ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; JOSAMYCIN; KETOLIDE; PRISTINAMYCIN; ROKITAMYCIN; TELITHROMYCIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MULTIDRUG RESISTANCE; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; SEPTICEMIA; STRAIN DIFFERENCE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BACTERIAL INFECTIONS; BIOLOGICAL AVAILABILITY; ERYTHROMYCIN; HALF-LIFE; INJECTIONS, INTRAVENOUS; KETOLIDES; MACROLIDES; MALE; MICE; MICROBIAL SENSITIVITY TESTS; VIRGINIAMYCIN;

EID: 0035019615     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.6.1688-1692.2001     Document Type: Article

References (14)

1. Barry, A. 1991. Procedures and theoretical considerations for testing antimicrobial agents in agar media, p. 1-16. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
2. Barry, A. L., P. C. Fuchs, and S. D. Brown. 1998. In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae. Antimicrob. Agents Chemother. 42:2138-2140.
3. Biedenbach, D. J., M. S. Barrett, and R. N. Jones. 1998. Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains. Diagn. Microbiol. Infect. Dis. 31:349-353.
4. Boswell, F. J., J. M. Andrews, J. P. Ashby, C. Fogarty, N. P. Brenwald, and R. Wise. 1998. The in vitro activity of HMR 3647, a new ketolide antimicrobial agent. J. Antimicrob. Chemother. 42:703-709.
5. Boswell, F. J., J. M. Andrews, and R. Wise. 1998. Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect. J. Antimicrob. Chemother. 41:149-153.
6. Cleeland, R., and E. Squires. 1991. Evaluation of new antimicrobials in vitro and in experimental animal infections, p. 739-786. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
7. Deguchi, K., N. Yokota, M. Koguchi, Y. Suzuki, S. Fukayama, R. Ishihara, and S. Oda. 1992. Antibacterial activity of rokitamycin against fresh clinical isolates. Jpn. J. Antibiot. 45:1609-1621.
8. Doern, G. V., M. A. Pfaller, K. Kugler, J. Freeman, and R. N. Jones. 1998. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin. Infect. Dis. 27:764-770.
9. Litchfield, J. T., and F. Wilcoxon. 1949. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:99-113.
10. Oster, P., A. Zanchi, S. Cresti, M. Lattanzi, F. Montagnani, C. Cellesi, and G. M. Rossolini. 1999. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. Antimicrob. Agents Chemother. 43:2510-2512.
11. Pankuch, G., D. B. Hoellman, G. Lin, S. Bajaksouzian, M. R. Jacobs, and P. C. Appelbaum. 1998. Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and Moraxella catarrhalis by MIC determination and time-kill assay. Antimicrob. Agents Chemother. 42:3032-3034.
12. Perez-Trallero, E. 2000. Pneumococcal macrolide resistance - not a myth. J. Antimicrob. Chemother. 45:401-402.
13. Piper, K. E., M. S. Rouse, J. M. Steckelberg, W. R. Wilson, and R. Patel. 1999. Ketolide treatment of Haemophilus influenzae experimental pneumonia. Antimicrob. Agents Chemother. 43:708-710.
14. Wootton, M., K. E. Bowker, A. Janowska, H. A. Holt, and A. P. MacGowan. 1999. In vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci. J. Antimicrob. Chemother. 44:445-453.